Organon & Co at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 03:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat this morning with the Organon management team.

From the company, we have CEO, Kevin Ali, as well as CFO, Matt Walsh. So Kevin and Matt, Happy New Year, and thanks for joining us this morning.

Kevin Ali - Organon & Co. - CEO & Director

Thank you.

Questions and Answers:

Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst

I thought maybe to kick things off, the company just completed its first full year as a standalone company. And at a high level, I'd love just to hear your thoughts of kind of what's gone well and maybe whether this surprises us as you've stopped the company and operate as an independent entity here?

Kevin Ali - Organon & Co. - CEO & Director

Well, good morning, Chris, and good to be here. And yes, I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot